BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15534609)

  • 1. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.
    Dickinson RE; Dallol A; Bieche I; Krex D; Morton D; Maher ER; Latif F
    Br J Cancer; 2004 Dec; 91(12):2071-8. PubMed ID: 15534609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the expression of Slit/Robo genes and the methylation status of their promoters in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):198-202. PubMed ID: 19335983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
    Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
    Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
    Kim M; Kim JH; Baek SJ; Kim SY; Kim YS
    Int J Oncol; 2016 Jun; 48(6):2497-507. PubMed ID: 27082735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomics on SLIT1, SLIT2, and SLIT3 orthologs.
    Katoh Y; Katoh M
    Oncol Rep; 2005 Nov; 14(5):1351-5. PubMed ID: 16211308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression.
    Narayan G; Goparaju C; Arias-Pulido H; Kaufmann AM; Schneider A; Dürst M; Mansukhani M; Pothuri B; Murty VV
    Mol Cancer; 2006 May; 5():16. PubMed ID: 16700909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.
    Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
    Oncogene; 2002 May; 21(19):3020-8. PubMed ID: 12082532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma.
    Astuti D; Da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
    Br J Cancer; 2004 Jan; 90(2):515-21. PubMed ID: 14735202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells.
    Dallol A; Morton D; Maher ER; Latif F
    Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
    Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
    Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas.
    Jin J; You H; Yu B; Deng Y; Tang N; Yao G; Shu H; Yang S; Qin W
    Biochem Biophys Res Commun; 2009 Jan; 379(1):86-91. PubMed ID: 19100240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
    Cooper WN; Dickinson RE; Dallol A; Grigorieva EV; Pavlova TV; Hesson LB; Bieche I; Broggini M; Maher ER; Zabarovsky ER; Clark GJ; Latif F
    Oncogene; 2008 Mar; 27(12):1805-11. PubMed ID: 17891178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.